Roger Sawhney
Found 9 people in New Jersey and New York
-
+99
-
+98
-
+97
-
-
+95
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sponsored by SpokeoPaid Service
Sponsored by SpokeoPaid Service
Roger Sawhney
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Roger Sawhney - @jngo777
3 followers
rogerswaney - @rogerswaney
124 followers
rogersawh - @rogersawh
307 followers
Shawney Rogers - @shawney.rogers
35 followers
Gad Berdugo
Nutcracker Therapeutics
Education: Northwestern ...
Roger W.
Founder & Managing Partner at Spruce Capital Partners
Ellen Lubman
Francesco Draetta
Omega Funds
Education: University of Massachusetts at Amherst - Isenberg School of Management
Thomas Forest Farb-Horch
MantaBio
Education: Harvard University
Fabrice Egros
Lupin
Education: Harvard Business School
Whit Bernard
Chief Executive Officer at Metsera
Elisabeth Leiderman, MD, MBA
Chief Financial Officer & Corporate ...
Experience: Dewpoint Therapeutics
Education: University of Pennsylvania - The Wharton School
Michael Dixon
Roger Sawhney
Sponsored by PeopleLookerPaid Service
Search for Roger Sawhney's city and state history
Search address historyArbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
The Globe and Mail - Wed, 06 Aug 2025
Arbutus Biopharma Appoints New Board Member Amid Strong Q2
TipRanks - Wed, 06 Aug 2025
Arbutus Biopharma Reports Q2 Earnings of $2.523mln, Revenue of $10.739mln, EPS of $0.01
AInvest - Wed, 06 Aug 2025
Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
The Manila Times - Wed, 06 Aug 2025
Garuda Therapeutics Appoints Roger Sawhney, M.D., as Chief Financial Officer
citybiz - Wed, 07 Sep 2022
Arbutus Biopharma Q2 Revenue Jumps 529%, Driven by One-Time Recognition of Deferred Revenue
AInvest - Wed, 06 Aug 2025
Arbutus Biopharma Q2 EPS $0.01 Beats Expectations, Revenue Jumps 520.8% Y/Y
AInvest - Wed, 06 Aug 2025
Arbutus Biopharma Reports Q2 2025 Revenue of $10.7M and Appoints New Board Members
SSBCrack - Wed, 06 Aug 2025
Roger Sawhney - Chief Financial Officer @ Omega Therapeutics
www.crunchbase.com
Roger Sawhney - LB Pharmaceuticals
Roger Sawhney has served as our Chief Financial Officer since June 2024. Dr. Sawhney most recently served as the Chief Financial Officer of Garuda Therapeutics ...
Roger Sawhney, MD | Board Member | Adlai Nortye Limited
Roger Sawhney serves as our independent director. Dr. Sawhney has nearly 30 years of financial and strategic expertise spanning the biopharma industry.
Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of Directors
... Roger Sawhney, M.D. to its Board of Directors as a director, effective August 8, 2024. Dr. Sawhney has nearly 30 years of financial and ...
Roger Sawhney MD Profile: Contact Information & Network | PitchBook
Dr. Roger Sawhney MD serves as Chief Financial Officer at LB Pharmaceuticals. How much does Roger Sawhney MD typically invest? Roger Sawhney MD's median deal ...
Roger Sawhney, MD | Board of Directors
Roger Sawhney, MD. Independent Director. Member of the Audit Committee · Member of the Corporate Governance and Nominating Committee. Shareholder Tools. Email ...
Omega Therapeutics, Inc. Offer Letter to Roger Sawhney for Chief
Omega Therapeutics, Inc. offers Roger Sawhney the position of Chief Financial Officer and SVP Business Development, starting no later than May 4, 2020.
SIRPant Immunotherapeutics Strengthens Board of Directors with ...
... Roger Sawhney, M.D. to its Board of Directors. Dr. Sawhney brings nearly 30 years of financial and strategic expertise spanning the ...
EX-10.19 - SEC.gov
EXECUTIVE. /s/ Roger Sawhney. Roger Sawhney, M.D.. [Signature Page to Employment Agreement]. EXHIBIT A. Separation Agreement and Release. This Separation ...
SIRPant Immunotherapeutics Strengthens Board of Directors with ...
SIRPant Immunotherapeutics Strengthens Board of Directors with Appointment of Roger Sawhney, M.D..
Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of Directors
Roger Sawhney brings nearly 30 years of financial and strategic expertise in the biopharma industry, including experience as CFO at various ...
Adlai Nortye (ANL) Appoints Roger Sawhney to Its Board
Adlai Nortye Ltd. (NASDAQ: ANL) today announced the appointment of Mr. Roger Sawhney, M.D. to its Board of Directors as a director, effective August 8, ...
Roger Sawhney Net Worth (2025) - GuruFocus
The estimated net worth of Roger Sawhney is at least $121 dollars as of 2025-04-13. Roger Sawhney is the CFO of Omega Therapeutics Inc and owns about 2,941 ...
Actuate Therapeutics Form 4 / Roger Sawhney ownership change
Actuate Therapeutics (ACTU) Form 4ACTUATE THERAPEUTICS / Roger Sawhney ownership change · 1. Name and Address of Reporting Person Sawhney Roger ...
Board of Directors | Actuate Therapeutics, Inc.
Board of Directors · Roger Sawhney · Amy Ronneberg · Jason Keyes · Todd Thomson · Dan Zabrowski, Ph.D. · Aaron G.L. Fletcher, Ph.D. · Daniel M. Schmitt.
Roger Sawhney's Insider Trades & SAST Disclosures - Trendlyne.com
Roger Sawhney's most recent trade in Actuate Therapeutics Inc. was a trade of 15,000 Stock Options done . Disclosure was reported to the exchange on May 22, ...
Roger Sawhney | Garuda Therapeutics, Inc. | Chief Financial Officer
Cambridge/Roger Sawhney. Roger Sawhney. Chief Financial Officer at Garuda Therapeutics, Inc. Get Full Access to Roger's Profile. OverviewColleaguesSimilar ...
Dr. Roger Sawhney, Internal Medicine | Short Hills, NJ | WebMD
Dr. Roger Sawhney, is an Internal Medicine specialist practicing in Short Hills, NJ with 30 years of experience. . New patients are welcome.
Omega Therapeutics Strengthens Leadership Team with ... - BioSpace
Roger Sawhney as Chief Financial Officer. Dr. Sawhney brings 25 years of financial and strategic expertise to Omega, with vast experience ...
Form 3 for Sawhney Roger filed 08/06/2025
No securities are beneficially owned. /s/ Tuan Nguyen as attorney-in-fact for. Roger Sawhney. 08/06/2025. ** Signature of Reporting Person. Date.
2022 director compensation-1 - Omega Therapeutics
Roger Sawhney, MD (7) , Former Chief Business Officer, 2022 2021, $ $, 239,167 ... Roger Sawhney, M.D, 193,261, *. 15, Noubar B. Afeyan, Ph.D. (1)(6 ...
Garuda Therapeutics Announces Appointment of Roger Sawhney ...
Garuda, a company creating off-the-shelf, durable blood stem cell therapies, today announced the appointment of Roger Sawhney, M.D., as CFO.
Committee Composition - Investor Relations | Adlai Nortye Limited
Roger Sawhney, MD, Member of the Audit Committee, Member of the Nominating and Corporate Governance Committee ; Shaorong Liu, Member of the Audit Committee ...
Arbutus Reports Second Quarter 2025 Financial Results and ...
Roger Sawhney, MD, joined the Board effective August 4, 2025. Dr. Sawhney is a seasoned executive and board member with extensive experience ...
-uju5o2q.html | Actuate Therapeutics, Inc.
... Roger Sawhney Member Member Amy Ronneberg. Corporate Governance Read More » · Stock Information · lsc-webmaster. STOCK INFORMATION Actuate Therapeutics, Inc.
SEC FORM 3
/s/ Tuan Nguyen as attorney-in-fact for Roger Sawhney, 08/06/2025. ** Signature of Reporting Person, Date. Reminder: Report on a separate line ...
Dr. Roger Anu Sawhney - Short Hills, NJ - Internal Medicine - Vitals
Roger Sawhney has not indicated that they accept virtual/teleheatlh appointments. Contact their office through their Vitals profile to check for availability.